Compliance Rate

Compliance Rate 53.0%
Compliant submissions 53
Incompliant submissions 47
Total trials 100

Your Clinical Trials

Showing 100 of 100 entries
View as:

A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

Phase: N/A Priority: Normal
NCT ID: NCT00000796 Org: User:
Start: - End: 10/31/98 Due: 10/31/99

Effect of Fluconazole, Clarithromycin, and Rifabutin on the Pharmacokinetics of Sulfamethoxazole-Trimethoprim and Dapsone and Their Hydroxylamine Metabolites

Phase: N/A Priority: Normal
NCT ID: NCT00000826 Org: User:
Start: - End: 05/31/99 Due: 05/31/00

A Study to Test the Safety of Three Experimental HIV Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT00000946 Org: User:
Start: - End: 03/31/01 Due: 03/31/02

Phase II Study of Filgrastim (G-CSF) Plus ABVD in the Treatment of HIV-Associated Hodgkin's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00000626 Org: User:
Start: - End: 02/28/99 Due: 02/28/00

A Phase I Safety and Immunogenicity Trial of HIV-1 gp120 C4-V3 Hybrid Polyvalent Peptide Immunogen Mixed in Mineral Oil Containing Mannose Mono-Oleate (IFA)

Phase: N/A Priority: Normal
NCT ID: NCT00000886 Org: User:
Start: - End: 04/30/99 Due: 04/30/00

Sodium Sensitivity in African Americans

Phase: N/A Priority: Normal
NCT ID: NCT00000536 Org: User:
Start: 07/31/92 End: 06/30/97 Due: 06/30/98

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Trial to Evaluate the Safety and Immunogenicity of the Therion Recombinant Vaccinia-HIV-1 IIIB ENV/GAG/POL Vaccine (TCB-3B) and MN RGP 120/HIV-1 In Alum.

Phase: N/A Priority: Normal
NCT ID: NCT00000866 Org: User:
Start: - End: 07/31/99 Due: 07/31/00

Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED)

Phase: N/A Priority: Normal
NCT ID: NCT00000566 Org: User:
Start: 09/30/83 End: 12/31/89 Due: 12/31/90

A Study of Azithromycin Plus Pyrimethamine in the Treatment of a Brain Infection in Patients With AIDS

Phase: N/A Priority: Normal
NCT ID: NCT00000966 Org: User:
Start: - End: - Due: -

A Randomized Prospective Study of Pyrimethamine Therapy for Prevention of Toxoplasmic Encephalitis in HIV-Infected Individuals With Serologic Evidence of Latent Toxoplasma Gondii Infection

Phase: N/A Priority: Normal
NCT ID: NCT00000666 Org: User:
Start: - End: 03/31/92 Due: 03/31/93

A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients

Phase: N/A Priority: Normal
NCT ID: NCT00000896 Org: User:
Start: - End: 10/31/00 Due: 10/31/01

A Phase I Multicenter Trial to Evaluate the Safety and Immunogenicity of HIV-1 Recombinant Envelope Glycoprotein gp160

Phase: N/A Priority: Normal
NCT ID: NCT00000956 Org: User:
Start: - End: 03/31/93 Due: 03/31/94

Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT)

Phase: N/A Priority: Normal
NCT ID: NCT00000136 Org: User:
Start: 03/31/90 End: 10/31/91 Due: 10/31/92

Studies of Left Ventricular Dysfunction (SOLVD)

Phase: N/A Priority: Normal
NCT ID: NCT00000516 Org: User:
Start: 07/31/85 End: 05/31/90 Due: 05/31/91

Unstable Angina Pectoris Trial

Phase: N/A Priority: Normal
NCT ID: NCT00000486 Org: User:
Start: 01/31/72 End: 01/31/80 Due: 01/31/81

Arthritis Patient Education for Urban African Americans

Phase: N/A Priority: Normal
NCT ID: NCT00000396 Org: User:
Start: 09/30/97 End: 10/31/02 Due: 10/31/03

Digitalis Investigation Group (DIG)

Phase: N/A Priority: Normal
NCT ID: NCT00000476 Org: User:
Start: 06/30/90 End: 06/30/98 Due: 06/30/99

Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment 1 - 1

Phase: N/A Priority: Normal
NCT ID: NCT00000326 Org: User:
Start: 04/30/97 End: 08/31/97 Due: 08/31/98

Behavior Therapy for Children and Adolescents With Obsessive-Compulsive Disorder (OCD)

Phase: N/A Priority: Normal
NCT ID: NCT00000386 Org: User:
Start: 12/31/98 End: 11/30/03 Due: 11/30/04

Rapid Benzodiazepine Detoxification Using Flumazenil - 1

Phase: N/A Priority: Normal
NCT ID: NCT00000246 Org: User:
Start: 01/31/93 End: 12/31/94 Due: 12/31/95

Randomized Trial of DHA for Retinitis Pigmentosa Patients Receiving Vitamin A

Phase: N/A Priority: Normal
NCT ID: NCT00000116 Org: User:
Start: 05/31/96 End: 09/30/02 Due: 09/30/03

Pentoxifylline (Trental) as a Modulator of Tumor Necrosis Factor and of HIV Replication in Patients With AIDS

Phase: N/A Priority: Normal
NCT ID: NCT00000646 Org: User:
Start: - End: 03/31/93 Due: 03/31/94

CMV Retinitis Retreatment Trial

Phase: N/A Priority: Normal
NCT ID: NCT00000766 Org: User:
Start: - End: - Due: -

A Phase I Trial To Evaluate the Safety and Immunogenicity of the UBI HIV-1MN PND Peptide Immunogen, Given by IM Injection, in Combination With the UBI Microparticulate Monovalent HIV-1 MN Branched Peptide Given Orally, in HIV-1 Uninfected Volunteers.

Phase: N/A Priority: Normal
NCT ID: NCT00000846 Org: User:
Start: - End: - Due: -

Optic Neuritis Treatment Trial (ONTT)

Phase: N/A Priority: Normal
NCT ID: NCT00000146 Org: User:
Start: 07/31/88 End: - Due: -